Atlas Trials

Study of the Effects of Intravenous Exenatide on Cardiac Repolarization

Clinical trial NCT02650479 · COMPLETED

Trial details

NCT number
NCT02650479
Sponsor
Intarcia Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Adult Male and Female Volunteers
Start date
2016-01-01
Primary completion
2016-04-01
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.